APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithrombin (Recombinant)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antithrombin (Recombinant) Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchAntithrombin (Recombinant) Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithrombin (Recombinant) Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Antithrombin (Recombinant) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithrombin (Recombinant) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithrombin (Recombinant) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Antithrombin (Recombinant) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antithrombin (Recombinant) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antithrombin (Recombinant) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antithrombin (Recombinant) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antithrombin (Recombinant) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antithrombin (Recombinant) include LFB Biotechnologies. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antithrombin (Recombinant), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antithrombin (Recombinant), also provides the sales of main regions and countries. Of the upcoming market potential for Antithrombin (Recombinant), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antithrombin (Recombinant) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antithrombin (Recombinant) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antithrombin (Recombinant) sales, projected growth trends, production technology, application and end-user industry.

Antithrombin (Recombinant) Segment by Company

LFB Biotechnologies

Antithrombin (Recombinant) Segment by Type

Lyophilized Formulation

Lyophilized Powder

Antithrombin (Recombinant) Segment by Application

Hospital

Clinic

Antithrombin (Recombinant) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithrombin (Recombinant) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithrombin (Recombinant) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithrombin (Recombinant).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antithrombin (Recombinant) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antithrombin (Recombinant) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antithrombin (Recombinant) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antithrombin (Recombinant) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lyophilized Formulation Major Manufacturers Table 3. Lyophilized Powder Major Manufacturers Table 4. Global Antithrombin (Recombinant) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Antithrombin (Recombinant) Industry Trends Table 8. Antithrombin (Recombinant) Industry Drivers Table 9. Antithrombin (Recombinant) Industry Opportunities and Challenges Table 10. Antithrombin (Recombinant) Industry Restraints Table 11. Global Antithrombin (Recombinant) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Antithrombin (Recombinant) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Antithrombin (Recombinant) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Antithrombin (Recombinant) Revenue Market Share by Region (2021-2026) Table 15. Global Antithrombin (Recombinant) Revenue Market Share by Region (2027-2032) Table 16. Global Antithrombin (Recombinant) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Antithrombin (Recombinant) Sales by Region (2021-2026) & (K Units) Table 18. Global Antithrombin (Recombinant) Sales by Region (2027-2032) & (K Units) Table 19. Global Antithrombin (Recombinant) Sales Market Share by Region (2021-2026) Table 20. Global Antithrombin (Recombinant) Sales Market Share by Region (2027-2032) Table 21. Global Antithrombin (Recombinant) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Antithrombin (Recombinant) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Antithrombin (Recombinant) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antithrombin (Recombinant) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Antithrombin (Recombinant) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Antithrombin (Recombinant) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Antithrombin (Recombinant) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Antithrombin (Recombinant) Manufacturers, Product Type & Application Table 29. Global Antithrombin (Recombinant) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Antithrombin (Recombinant) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Antithrombin (Recombinant) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antithrombin (Recombinant) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Antithrombin (Recombinant) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Antithrombin (Recombinant) Revenue Market Share by Type (2021-2026) Table 36. Global Antithrombin (Recombinant) Revenue Market Share by Type (2027-2032) Table 37. Global Antithrombin (Recombinant) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Antithrombin (Recombinant) Sales by Type (2021-2026) & (K Units) Table 39. Global Antithrombin (Recombinant) Sales by Type (2027-2032) & (K Units) Table 40. Global Antithrombin (Recombinant) Sales Market Share by Type (2021-2026) Table 41. Global Antithrombin (Recombinant) Sales Market Share by Type (2027-2032) Table 42. Global Antithrombin (Recombinant) Price by Type (2021-2026) & (US$/Unit) Table 43. Global Antithrombin (Recombinant) Price by Type (2027-2032) & (US$/Unit) Table 44. Global Antithrombin (Recombinant) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Antithrombin (Recombinant) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Antithrombin (Recombinant) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Antithrombin (Recombinant) Revenue Market Share by Application (2021-2026) Table 48. Global Antithrombin (Recombinant) Revenue Market Share by Application (2027-2032) Table 49. Global Antithrombin (Recombinant) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Antithrombin (Recombinant) Sales by Application (2021-2026) & (K Units) Table 51. Global Antithrombin (Recombinant) Sales by Application (2027-2032) & (K Units) Table 52. Global Antithrombin (Recombinant) Sales Market Share by Application (2021-2026) Table 53. Global Antithrombin (Recombinant) Sales Market Share by Application (2027-2032) Table 54. Global Antithrombin (Recombinant) Price by Application (2021-2026) & (US$/Unit) Table 55. Global Antithrombin (Recombinant) Price by Application (2027-2032) & (US$/Unit) Table 56. LFB Biotechnologies Company Information Table 57. LFB Biotechnologies Business Overview Table 58. LFB Biotechnologies Antithrombin (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. LFB Biotechnologies Antithrombin (Recombinant) Product Portfolio Table 60. LFB Biotechnologies Recent Development Table 61. North America Antithrombin (Recombinant) Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Antithrombin (Recombinant) Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Antithrombin (Recombinant) Sales by Type (2021-2026) & (K Units) Table 64. North America Antithrombin (Recombinant) Sales by Type (2027-2032) & (K Units) Table 65. North America Antithrombin (Recombinant) Sales Price by Type (2021-2026) & (US$/Unit) Table 66. North America Antithrombin (Recombinant) Sales Price by Type (2027-2032) & (US$/Unit) Table 67. North America Antithrombin (Recombinant) Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Antithrombin (Recombinant) Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Antithrombin (Recombinant) Sales by Application (2021-2026) & (K Units) Table 70. North America Antithrombin (Recombinant) Sales by Application (2027-2032) & (K Units) Table 71. North America Antithrombin (Recombinant) Sales Price by Application (2021-2026) & (US$/Unit) Table 72. North America Antithrombin (Recombinant) Sales Price by Application (2027-2032) & (US$/Unit) Table 73. North America Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Antithrombin (Recombinant) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Antithrombin (Recombinant) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 77. North America Antithrombin (Recombinant) Sales by Country (2021-2026) & (K Units) Table 78. North America Antithrombin (Recombinant) Sales by Country (2027-2032) & (K Units) Table 79. North America Antithrombin (Recombinant) Sales Price by Country (2021-2026) & (US$/Unit) Table 80. North America Antithrombin (Recombinant) Sales Price by Country (2027-2032) & (US$/Unit) Table 81. United States Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 82. Canada Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 83. Europe Antithrombin (Recombinant) Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Antithrombin (Recombinant) Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Antithrombin (Recombinant) Sales by Type (2021-2026) & (K Units) Table 86. Europe Antithrombin (Recombinant) Sales by Type (2027-2032) & (K Units) Table 87. Europe Antithrombin (Recombinant) Sales Price by Type (2021-2026) & (US$/Unit) Table 88. Europe Antithrombin (Recombinant) Sales Price by Type (2027-2032) & (US$/Unit) Table 89. Europe Antithrombin (Recombinant) Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Antithrombin (Recombinant) Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Antithrombin (Recombinant) Sales by Application (2021-2026) & (K Units) Table 92. Europe Antithrombin (Recombinant) Sales by Application (2027-2032) & (K Units) Table 93. Europe Antithrombin (Recombinant) Sales Price by Application (2021-2026) & (US$/Unit) Table 94. Europe Antithrombin (Recombinant) Sales Price by Application (2027-2032) & (US$/Unit) Table 95. Europe Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Antithrombin (Recombinant) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. Europe Antithrombin (Recombinant) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. Europe Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 99. Europe Antithrombin (Recombinant) Sales by Country (2021-2026) & (K Units) Table 100. Europe Antithrombin (Recombinant) Sales by Country (2027-2032) & (K Units) Table 101. Europe Antithrombin (Recombinant) Sales Price by Country (2021-2026) & (US$/Unit) Table 102. Europe Antithrombin (Recombinant) Sales Price by Country (2027-2032) & (US$/Unit) Table 103. Germany Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 104. France Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 105. U.K. Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 106. Italy Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 107. Netherlands Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 108. China Antithrombin (Recombinant) Revenue by Type (2021-2026) & (US$ Million) Table 109. China Antithrombin (Recombinant) Revenue by Type (2027-2032) & (US$ Million) Table 110. China Antithrombin (Recombinant) Sales by Type (2021-2026) & (K Units) Table 111. China Antithrombin (Recombinant) Sales by Type (2027-2032) & (K Units) Table 112. China Antithrombin (Recombinant) Sales Price by Type (2021-2026) & (US$/Unit) Table 113. China Antithrombin (Recombinant) Sales Price by Type (2027-2032) & (US$/Unit) Table 114. China Antithrombin (Recombinant) Revenue by Application (2021-2026) & (US$ Million) Table 115. China Antithrombin (Recombinant) Revenue by Application (2027-2032) & (US$ Million) Table 116. China Antithrombin (Recombinant) Sales by Application (2021-2026) & (K Units) Table 117. China Antithrombin (Recombinant) Sales by Application (2027-2032) & (K Units) Table 118. China Antithrombin (Recombinant) Sales Price by Application (2021-2026) & (US$/Unit) Table 119. China Antithrombin (Recombinant) Sales Price by Application (2027-2032) & (US$/Unit) Table 120. Asia Antithrombin (Recombinant) Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Antithrombin (Recombinant) Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Antithrombin (Recombinant) Sales by Type (2021-2026) & (K Units) Table 123. Asia Antithrombin (Recombinant) Sales by Type (2027-2032) & (K Units) Table 124. Asia Antithrombin (Recombinant) Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Asia Antithrombin (Recombinant) Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Asia Antithrombin (Recombinant) Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia Antithrombin (Recombinant) Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Antithrombin (Recombinant) Sales by Application (2021-2026) & (K Units) Table 129. Asia Antithrombin (Recombinant) Sales by Application (2027-2032) & (K Units) Table 130. Asia Antithrombin (Recombinant) Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Asia Antithrombin (Recombinant) Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Antithrombin (Recombinant) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Asia Antithrombin (Recombinant) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Asia Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Asia Antithrombin (Recombinant) Sales by Country (2021-2026) & (K Units) Table 137. Asia Antithrombin (Recombinant) Sales by Country (2027-2032) & (K Units) Table 138. Asia Antithrombin (Recombinant) Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Asia Antithrombin (Recombinant) Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Japan Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 141. South Korea Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 142. India Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 143. Australia Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 144. China Taiwan Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 145. Southeast Asia Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 146. SAMEA Antithrombin (Recombinant) Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Antithrombin (Recombinant) Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Antithrombin (Recombinant) Sales by Type (2021-2026) & (K Units) Table 149. SAMEA Antithrombin (Recombinant) Sales by Type (2027-2032) & (K Units) Table 150. SAMEA Antithrombin (Recombinant) Sales Price by Type (2021-2026) & (US$/Unit) Table 151. SAMEA Antithrombin (Recombinant) Sales Price by Type (2027-2032) & (US$/Unit) Table 152. SAMEA Antithrombin (Recombinant) Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Antithrombin (Recombinant) Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Antithrombin (Recombinant) Sales by Application (2021-2026) & (K Units) Table 155. SAMEA Antithrombin (Recombinant) Sales by Application (2027-2032) & (K Units) Table 156. SAMEA Antithrombin (Recombinant) Sales Price by Application (2021-2026) & (US$/Unit) Table 157. SAMEA Antithrombin (Recombinant) Sales Price by Application (2027-2032) & (US$/Unit) Table 158. SAMEA Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Antithrombin (Recombinant) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. SAMEA Antithrombin (Recombinant) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. SAMEA Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. SAMEA Antithrombin (Recombinant) Sales by Country (2021-2026) & (K Units) Table 163. SAMEA Antithrombin (Recombinant) Sales by Country (2027-2032) & (K Units) Table 164. SAMEA Antithrombin (Recombinant) Sales Price by Country (2021-2026) & (US$/Unit) Table 165. SAMEA Antithrombin (Recombinant) Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Brazil Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 167. Argentina Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 168. Chile Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 169. Colombia Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 170. Peru Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 171. Saudi Arabia Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 172. Israel Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 173. UAE Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 174. Turkey Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 175. Iran Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 176. Egypt Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Antithrombin (Recombinant) Distributors List Table 180. Antithrombin (Recombinant) Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Antithrombin (Recombinant) Image Figure 2. Global Antithrombin (Recombinant) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithrombin (Recombinant) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lyophilized Formulation Image Figure 5. Lyophilized Powder Image Figure 6. Global Antithrombin (Recombinant) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antithrombin (Recombinant) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Antithrombin (Recombinant) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Antithrombin (Recombinant) Revenue (2021-2032) & (US$ Million) Figure 12. Global Antithrombin (Recombinant) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Antithrombin (Recombinant) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Antithrombin (Recombinant) Revenue Market Share by Region (2021-2032) Figure 15. Global Antithrombin (Recombinant) Sales (2021-2032) & (K Units) Figure 16. Global Antithrombin (Recombinant) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Antithrombin (Recombinant) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Antithrombin (Recombinant) Sales YoY (2021-2032) & (K Units) Figure 19. Europe Antithrombin (Recombinant) Sales YoY (2021-2032) & (K Units) Figure 20. China Antithrombin (Recombinant) Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Antithrombin (Recombinant) Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Antithrombin (Recombinant) Sales YoY (2021-2032) & (K Units) Figure 23. Global Antithrombin (Recombinant) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Antithrombin (Recombinant) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Antithrombin (Recombinant) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antithrombin (Recombinant) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Antithrombin (Recombinant) Revenue Market Share by Type (2021-2032) Figure 29. Global Antithrombin (Recombinant) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Antithrombin (Recombinant) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Antithrombin (Recombinant) Sales Market Share by Type (2021-2032) Figure 32. Global Antithrombin (Recombinant) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Antithrombin (Recombinant) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Antithrombin (Recombinant) Revenue Market Share by Application (2021-2032) Figure 35. Global Antithrombin (Recombinant) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Antithrombin (Recombinant) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Antithrombin (Recombinant) Sales Market Share by Application (2021-2032) Figure 38. North America Antithrombin (Recombinant) Revenue Share by Type (2021-2032) Figure 39. North America Antithrombin (Recombinant) Sales Share by Type (2021-2032) Figure 40. North America Antithrombin (Recombinant) Revenue Share by Application (2021-2032) Figure 41. North America Antithrombin (Recombinant) Sales Share by Application (2021-2032) Figure 42. North America Antithrombin (Recombinant) Revenue Share by Country (2021-2032) Figure 43. North America Antithrombin (Recombinant) Sales Share by Country (2021-2032) Figure 44. Europe Antithrombin (Recombinant) Revenue Share by Type (2021-2032) Figure 45. Europe Antithrombin (Recombinant) Sales Share by Type (2021-2032) Figure 46. Europe Antithrombin (Recombinant) Revenue Share by Application (2021-2032) Figure 47. Europe Antithrombin (Recombinant) Sales Share by Application (2021-2032) Figure 48. Europe Antithrombin (Recombinant) Revenue Share by Country (2021-2032) Figure 49. Europe Antithrombin (Recombinant) Sales Share by Country (2021-2032) Figure 50. China Antithrombin (Recombinant) Revenue Share by Type (2021-2032) Figure 51. China Antithrombin (Recombinant) Sales Share by Type (2021-2032) Figure 52. China Antithrombin (Recombinant) Revenue Share by Application (2021-2032) Figure 53. China Antithrombin (Recombinant) Sales Share by Application (2021-2032) Figure 54. Asia Antithrombin (Recombinant) Revenue Share by Type (2021-2032) Figure 55. Asia Antithrombin (Recombinant) Sales Share by Type (2021-2032) Figure 56. Asia Antithrombin (Recombinant) Revenue Share by Application (2021-2032) Figure 57. Asia Antithrombin (Recombinant) Sales Share by Application (2021-2032) Figure 58. Asia Antithrombin (Recombinant) Revenue Share by Country (2021-2032) Figure 59. Asia Antithrombin (Recombinant) Sales Share by Country (2021-2032) Figure 60. SAMEA Antithrombin (Recombinant) Revenue Share by Type (2021-2032) Figure 61. SAMEA Antithrombin (Recombinant) Sales Share by Type (2021-2032) Figure 62. SAMEA Antithrombin (Recombinant) Revenue Share by Application (2021-2032) Figure 63. SAMEA Antithrombin (Recombinant) Sales Share by Application (2021-2032) Figure 64. SAMEA Antithrombin (Recombinant) Revenue Share by Country (2021-2032) Figure 65. SAMEA Antithrombin (Recombinant) Sales Share by Country (2021-2032) Figure 66. Antithrombin (Recombinant) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antithrombin (Recombinant) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized Formulation
  • Lyophilized Powder
Applications
  • Hospital
  • Clinic
Companies covered
  • LFB Biotechnologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antithrombin (Recombinant) Market by Type
  3. 1.2.1 Global Antithrombin (Recombinant) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lyophilized Formulation
  5. 1.2.3 Lyophilized Powder
  6. 1.3 Antithrombin (Recombinant) Market by Application
  7. 1.3.1 Global Antithrombin (Recombinant) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Antithrombin (Recombinant) Market Dynamics
  1. 2.1 Antithrombin (Recombinant) Industry Trends
  2. 2.2 Antithrombin (Recombinant) Industry Drivers
  3. 2.3 Antithrombin (Recombinant) Industry Opportunities and Challenges
  4. 2.4 Antithrombin (Recombinant) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antithrombin (Recombinant) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antithrombin (Recombinant) Revenue by Region
  3. 3.2.1 Global Antithrombin (Recombinant) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antithrombin (Recombinant) Revenue by Region (2021-2026)
  5. 3.2.3 Global Antithrombin (Recombinant) Revenue by Region (2027-2032)
  6. 3.2.4 Global Antithrombin (Recombinant) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antithrombin (Recombinant) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antithrombin (Recombinant) Sales by Region
  9. 3.4.1 Global Antithrombin (Recombinant) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antithrombin (Recombinant) Sales by Region (2021-2026)
  11. 3.4.3 Global Antithrombin (Recombinant) Sales by Region (2027-2032)
  12. 3.4.4 Global Antithrombin (Recombinant) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antithrombin (Recombinant) Revenue by Manufacturers
  2. 4.1.1 Global Antithrombin (Recombinant) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antithrombin (Recombinant) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antithrombin (Recombinant) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antithrombin (Recombinant) Sales by Manufacturers
  6. 4.2.1 Global Antithrombin (Recombinant) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antithrombin (Recombinant) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antithrombin (Recombinant) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antithrombin (Recombinant) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antithrombin (Recombinant) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antithrombin (Recombinant) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antithrombin (Recombinant) Manufacturers, Product Type & Application
  13. 4.7 Global Antithrombin (Recombinant) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antithrombin (Recombinant) Market CR5 and HHI
  16. 4.8.2 2025 Antithrombin (Recombinant) Tier 1, Tier 2, and Tier 3
5 Antithrombin (Recombinant) Market by Type
  1. 5.1 Global Antithrombin (Recombinant) Revenue by Type
  2. 5.1.1 Global Antithrombin (Recombinant) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antithrombin (Recombinant) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antithrombin (Recombinant) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antithrombin (Recombinant) Sales by Type
  6. 5.2.1 Global Antithrombin (Recombinant) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antithrombin (Recombinant) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Antithrombin (Recombinant) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antithrombin (Recombinant) Price by Type
6 Antithrombin (Recombinant) Market by Application
  1. 6.1 Global Antithrombin (Recombinant) Revenue by Application
  2. 6.1.1 Global Antithrombin (Recombinant) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antithrombin (Recombinant) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antithrombin (Recombinant) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antithrombin (Recombinant) Sales by Application
  6. 6.2.1 Global Antithrombin (Recombinant) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antithrombin (Recombinant) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Antithrombin (Recombinant) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antithrombin (Recombinant) Price by Application
7 Company Profiles
  1. 7.1 LFB Biotechnologies
  2. 7.1.1 LFB Biotechnologies Company Information
  3. 7.1.2 LFB Biotechnologies Business Overview
  4. 7.1.3 LFB Biotechnologies Antithrombin (Recombinant) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 LFB Biotechnologies Antithrombin (Recombinant) Product Portfolio
  6. 7.1.5 LFB Biotechnologies Recent Developments
8 North America
  1. 8.1 North America Antithrombin (Recombinant) Market Size by Type
  2. 8.1.1 North America Antithrombin (Recombinant) Revenue by Type (2021-2032)
  3. 8.1.2 North America Antithrombin (Recombinant) Sales by Type (2021-2032)
  4. 8.1.3 North America Antithrombin (Recombinant) Price by Type (2021-2032)
  5. 8.2 North America Antithrombin (Recombinant) Market Size by Application
  6. 8.2.1 North America Antithrombin (Recombinant) Revenue by Application (2021-2032)
  7. 8.2.2 North America Antithrombin (Recombinant) Sales by Application (2021-2032)
  8. 8.2.3 North America Antithrombin (Recombinant) Price by Application (2021-2032)
  9. 8.3 North America Antithrombin (Recombinant) Market Size by Country
  10. 8.3.1 North America Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antithrombin (Recombinant) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Antithrombin (Recombinant) Market Size by Type
  2. 9.1.1 Europe Antithrombin (Recombinant) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antithrombin (Recombinant) Sales by Type (2021-2032)
  4. 9.1.3 Europe Antithrombin (Recombinant) Price by Type (2021-2032)
  5. 9.2 Europe Antithrombin (Recombinant) Market Size by Application
  6. 9.2.1 Europe Antithrombin (Recombinant) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antithrombin (Recombinant) Sales by Application (2021-2032)
  8. 9.2.3 Europe Antithrombin (Recombinant) Price by Application (2021-2032)
  9. 9.3 Europe Antithrombin (Recombinant) Market Size by Country
  10. 9.3.1 Europe Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antithrombin (Recombinant) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Antithrombin (Recombinant) Market Size by Type
  2. 10.1.1 China Antithrombin (Recombinant) Revenue by Type (2021-2032)
  3. 10.1.2 China Antithrombin (Recombinant) Sales by Type (2021-2032)
  4. 10.1.3 China Antithrombin (Recombinant) Price by Type (2021-2032)
  5. 10.2 China Antithrombin (Recombinant) Market Size by Application
  6. 10.2.1 China Antithrombin (Recombinant) Revenue by Application (2021-2032)
  7. 10.2.2 China Antithrombin (Recombinant) Sales by Application (2021-2032)
  8. 10.2.3 China Antithrombin (Recombinant) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antithrombin (Recombinant) Market Size by Type
  2. 11.1.1 Asia Antithrombin (Recombinant) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antithrombin (Recombinant) Sales by Type (2021-2032)
  4. 11.1.3 Asia Antithrombin (Recombinant) Price by Type (2021-2032)
  5. 11.2 Asia Antithrombin (Recombinant) Market Size by Application
  6. 11.2.1 Asia Antithrombin (Recombinant) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antithrombin (Recombinant) Sales by Application (2021-2032)
  8. 11.2.3 Asia Antithrombin (Recombinant) Price by Application (2021-2032)
  9. 11.3 Asia Antithrombin (Recombinant) Market Size by Country
  10. 11.3.1 Asia Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antithrombin (Recombinant) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antithrombin (Recombinant) Market Size by Type
  2. 12.1.1 SAMEA Antithrombin (Recombinant) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antithrombin (Recombinant) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antithrombin (Recombinant) Price by Type (2021-2032)
  5. 12.2 SAMEA Antithrombin (Recombinant) Market Size by Application
  6. 12.2.1 SAMEA Antithrombin (Recombinant) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antithrombin (Recombinant) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antithrombin (Recombinant) Price by Application (2021-2032)
  9. 12.3 SAMEA Antithrombin (Recombinant) Market Size by Country
  10. 12.3.1 SAMEA Antithrombin (Recombinant) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antithrombin (Recombinant) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antithrombin (Recombinant) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antithrombin (Recombinant) Value Chain Analysis
  2. 13.1.1 Antithrombin (Recombinant) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antithrombin (Recombinant) Production Mode & Process
  6. 13.2 Antithrombin (Recombinant) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antithrombin (Recombinant) Distributors
  9. 13.2.3 Antithrombin (Recombinant) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst